I. Expression across cell types
Name | Number of supported studies  | Average coverage | |
|---|---|---|---|
| B cell | 9 studies | 19% ± 5% | |
| naive B cell | 7 studies | 20% ± 4% | |
| endothelial cell | 7 studies | 23% ± 6% | |
| CD4-positive, alpha-beta T cell | 6 studies | 19% ± 4% | |
| epithelial cell | 6 studies | 30% ± 14% | |
| natural killer cell | 5 studies | 18% ± 2% | |
| retinal rod cell | 5 studies | 21% ± 4% | |
| regulatory T cell | 5 studies | 18% ± 3% | |
| memory B cell | 4 studies | 16% ± 1% | |
| CD8-positive, alpha-beta T cell | 4 studies | 23% ± 6% | |
| macrophage | 4 studies | 20% ± 3% | |
| plasmacytoid dendritic cell | 4 studies | 22% ± 7% | |
| CD16-negative, CD56-bright natural killer cell, human | 3 studies | 18% ± 2% | |
| classical monocyte | 3 studies | 20% ± 5% | |
| exhausted T cell | 3 studies | 20% ± 5% | |
| naive thymus-derived CD4-positive, alpha-beta T cell | 3 studies | 17% ± 1% | |
| naive thymus-derived CD8-positive, alpha-beta T cell | 3 studies | 19% ± 2% | |
| precursor B cell | 3 studies | 20% ± 1% | |
| ciliated cell | 3 studies | 24% ± 4% | |
| astrocyte | 3 studies | 23% ± 4% | |
| glutamatergic neuron | 3 studies | 36% ± 11% | |
| dendritic cell | 3 studies | 28% ± 5% | |
| basal cell | 3 studies | 25% ± 7% | |
| oligodendrocyte | 3 studies | 24% ± 3% |
